HLB Life Science Co. Ltd Capital Reinvestment Ratio
HLB Life Science Co. Ltd capital reinvestment ratio. HLB Life Science Co. Ltd (067630) has a Capital Reinvestment Ratio of 0.99x as of March 2023, meaning it reinvests 1% of its operating cash flow (₩3.55 Billion) in capital expenditures (₩3.52 Billion). See 067630 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of HLB Life Science Co. Ltd (2012–2020)
Capital reinvestment ratio of HLB Life Science Co. Ltd from 2012 to 2020. This chart tracks HLB Life Science Co. Ltd's Capital Reinvestment Ratio across 4 annual periods. See 067630 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
HLB Life Science Co. Ltd Capital Reinvestment Ratio by Year (2012–2020)
HLB Life Science Co. Ltd capital reinvestment ratio by year from 2012 to 2020. For the full cash flow conversion analysis, see HLB Life Science Co. Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 4.18x | ₩2.01 Billion | ₩8.41 Billion | ▲ +18377.9% |
| 2014 | 0.02x | ₩10.43 Billion | ₩236.21 Million | ▲ +29.7% |
| 2013 | 0.02x | ₩2.95 Billion | ₩51.48 Million | ▼ -97.3% |
| 2012 | 0.66x | ₩13.97 Billion | ₩9.18 Billion | — |